ABUS vs TEAM
Arbutus Biopharma Corp (ABUS) versus Atlassian Corp Plc (TEAM) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Atlassian Corp Plc (TEAM) is a software - application company listed on NASDAQ. It is led by Mike Cannon-Brookes.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported TEAM revenue for 2026-06-30 was $6.57B. Net income was -$53.8M. Revenue was up 26.0% from 2025-06-30 to 2026-06-30. TEAM currently screens at market cap $22.01B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. TEAM currently screens at market cap $22.01B.
Not investment advice. Open the ABUS and TEAM stock pages for the full models.
Not investment advice.